Homology model of dihydropyridine receptor: implications for L-type Ca(2+) channel modulation by agonists and antagonists.

L-type calcium channels (LCCs) are transmembrane (TM) proteins that respond to membrane depolarization by selectively permeating Ca(2+) ions. Dihydropyridine (DHP) agonists and antagonist modulate Ca(2+) permeation by stabilizing, respectively, the open and closed states of the channel. The mechanism of action of these drugs remains unclear. Using, as a template, the crystal structure of the KcsA K(+) channel (Doyle et al. (1998) Science 280, 69-77), we have built several homology models of LCC with alternative alignments of TM segments between the proteins. In each model, nifedipine was docked in the pore region and in the interface between repeats III and IV. Several starting structures were generated by constraining the ligand to residues whose mutations reportedly affect DHP binding (DHP-sensing residues). These structures were Monte Carlo-minimized with and without constraints. In the complex with the maximum number of contacts between the ligand and DHP-sensing residues and the lowest ligand-receptor energy, the drug fits snugly in the "water-lake" cavity between segments S6s, which were aligned with M2 segment of KcsA as proposed for Na(+) channel (Lipkind and Fozzard (2000) Biochemistry 39, 8161-8170). In the flattened-boat conformation of DHP ring, the NH group at the stern approaches the DHP-sensing tyrosines in segments IIIS6 and IVS6. Stacking interactions of IVS6 Tyr with the bowsprit aromatic ring stabilize the ligand's orientation in which the starboard COOMe group coordinates Ca(2+) ion chelated by two conserved glutamates in the selectivity filter. In the inverted teepee structure of LCC, the portside COOMe group approaches a bracelet of conserved hydrophobic residues at the helical-bundle crossing, which may function as the activation gate. The dimensions of the gate may readily change upon small rotation of the pore-forming TM segments. The end of the portside group is hydrophobic in nifedipine, (R)-Bay K 8644, and other antagonists. Favorable interactions of this group with the hydrophobic bracelet would stabilize its closed conformation. In contrast, (S)-Bay K 8644 and several other agonists have hydrophilic groups at the portside. Unfavorable interactions of the hydrophilic group with the hydrophobic bracelet would destabilize its closed conformation thereby stabilizing the open conformation. In the agonist-bound channel, Ca(2+) ions would permeate between the hydrophilic face of the ligand and conserved hydrophilic residues in segments IS6 and IIS6. Our model suggests mutational experiments that could further our understanding of the pharmacological modulation of voltage-gated ion channels.

[1]  C. Armstrong Interaction of Tetraethylammonium Ion Derivatives with the Potassium Channels of Giant Axons , 1971, The Journal of general physiology.

[2]  H. Glossmann,et al.  Coordination of Ca2+ by the pore region glutamates is essential for high-affinity dihydropyridine binding to the cardiac Ca2+ channel alpha 1 subunit. , 1995, Biochemistry.

[3]  E. Mccleskey,et al.  Ion Channel Selectivity through Stepwise Changes in Binding Affinity , 1998, The Journal of general physiology.

[4]  B. Eisenberg,et al.  Binding and selectivity in L-type calcium channels: a mean spherical approximation. , 2000, Biophysical journal.

[5]  R. Kass,et al.  Influence of pHo on calcium channel block by amlodipine, a charged dihydropyridine compound. Implications for location of the dihydropyridine receptor , 1989, The Journal of general physiology.

[6]  W. Catterall,et al.  Molecular determinants of state-dependent block of Na+ channels by local anesthetics. , 1994, Science.

[7]  W. Catterall,et al.  Molecular determinants of drug binding and action on L-type calcium channels. , 1997, Annual review of pharmacology and toxicology.

[8]  S. Cannon,et al.  Rapid and slow voltage-dependent conformational changes in segment IVS6 of voltage-gated Na(+) channels. , 2000, Biophysical journal.

[9]  Y. Kwan,et al.  Inhibition of cardiac L-type calcium channels by quaternary amlodipine: implications for pharmacokinetics and access to dihydropyridine binding site. , 1995, Journal of molecular and cellular cardiology.

[10]  V. Ananthanarayanan,et al.  Structural model of a synthetic Ca2+ channel with bound Ca2+ ions and dihydropyridine ligand. , 1996, Biophysical journal.

[11]  E. Perozo,et al.  Structural rearrangements underlying K+-channel activation gating. , 1999, Science.

[12]  Y. Mori,et al.  Structural determinants of ion selectivity in brain calcium channel , 1993, FEBS letters.

[13]  C. Strübing,et al.  Evidence for an external location of the dihydropyridine agonist receptor site on smooth muscle and skeletal muscle calcium channels , 1993, British journal of pharmacology.

[14]  A. Schwartz,et al.  Motif III S5 of L-type Calcium Channels Is Involved in the Dihydropyridine Binding Site , 1997, The Journal of Biological Chemistry.

[15]  Sheryl E. Koch,et al.  Molecular elements of ion permeation and selectivity within calcium channels. , 1999, Critical reviews in biochemistry and molecular biology.

[16]  D. Triggle,et al.  Permanently charged chiral 1,4-dihydropyridines: molecular probes of L-type calcium channels. Synthesis and pharmacological characterization of methyl(omega-trimethylalkylammonium) 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate iodide, calcium channel antagonists. , 2000, Journal of medicinal chemistry.

[17]  S. Y. Wang,et al.  Local anesthetic block of batrachotoxin-resistant muscle Na+ channels. , 1998, Molecular pharmacology.

[18]  M. Nakasako,et al.  Crystal structure of the calcium pump of sarcoplasmic reticulum at 2.6 Å resolution , 2000, Nature.

[19]  R. Tsien,et al.  Molecular basis of proton block of L-type Ca2+ channels , 1996, The Journal of general physiology.

[20]  A. Bahinski,et al.  Differential contribution by conserved glutamate residues to an ion‐selectivity site in the L‐type Ca2+ channel pore , 1993, FEBS letters.

[21]  Gary Yellen,et al.  The bacterial K+ channel structure and its implications for neuronal channels , 1999, Current Opinion in Neurobiology.

[22]  S. Y. Wang,et al.  Residues in Na(+) channel D3-S6 segment modulate both batrachotoxin and local anesthetic affinities. , 2000, Biophysical journal.

[23]  S. Y. Wang,et al.  Batrachotoxin-resistant Na+ channels derived from point mutations in transmembrane segment D4-S6. , 1999, Biophysical journal.

[24]  Ruiping Huang,et al.  Poly-3-hydroxybutyrate/polyphosphate complexes form voltage-activated Ca2+ channels in the plasma membranes of Escherichia coli. , 1995, Biophysical journal.

[25]  U. Singh,et al.  A NEW FORCE FIELD FOR MOLECULAR MECHANICAL SIMULATION OF NUCLEIC ACIDS AND PROTEINS , 1984 .

[26]  K. Itagaki,et al.  Identification of 1,4‐dihydropyridine binding domains within the primary structure of the α1 subunit of the skeletal muscle L‐type calcium channel , 1993, FEBS letters.

[27]  Y. Okamura,et al.  Serine Residue in the IIIS5-S6 Linker of the L-type Ca2+ Channel α1C Subunit Is the Critical Determinant of the Action of Dihydropyridine Ca2+Channel Agonists* , 2000, The Journal of Biological Chemistry.

[28]  R. Wagner,et al.  Exploring the open pore of the potassium channel from Streptomyces lividans , 1999, FEBS letters.

[29]  H. Guy,et al.  A putative prokaryote voltage-gated Ca(2+) channel with only one 6TM motif per subunit. , 2001, Biochemical and biophysical research communications.

[30]  W. Catterall,et al.  Receptor sites for Ca2+ channel antagonists. , 1992, Trends in pharmacological sciences.

[31]  N. Klugbauer,et al.  Alternatively spliced IS6 segments of the alpha 1C gene determine the tissue-specific dihydropyridine sensitivity of cardiac and vascular smooth muscle L-type Ca2+ channels. , 1997, Circulation research.

[32]  Boris S. Zhorov,et al.  A vector method for calculating the derivatives of the energy of the atom-atom interactions of complex molecules with respect to generalized coordinates , 1981 .

[33]  H. Fozzard,et al.  KcsA crystal structure as framework for a molecular model of the Na(+) channel pore. , 2000, Biochemistry.

[34]  T. Langer,et al.  Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain. , 2000, The Biochemical journal.

[35]  R. Kass,et al.  Block of L-type calcium channels by charged dihydropyridines. Sensitivity to side of application and calcium , 1991, The Journal of general physiology.

[36]  R. Kass,et al.  L-type calcium channels: asymmetrical intramembrane binding domain revealed by variable length, permanently charged 1,4-dihydropyridines. , 1994, Molecular Pharmacology.

[37]  R. Tsien,et al.  Ca2+ channel selectivity at a single locus for high-affinity Ca2+ interactions , 1995, Neuron.

[38]  Eduardo Perozo,et al.  Three-dimensional architecture and gating mechanism of a K+ channel studied by EPR spectroscopy , 1998, Nature Structural Biology.

[39]  D. Rhodes,et al.  Interaction of 1,4 dihydropyridine calcium channel antagonists with biological membranes: lipid bilayer partitioning could occur before drug binding to receptors. , 1989, Journal of molecular and cellular cardiology.

[40]  R. Tsien,et al.  Molecular determinants of Ca2+ selectivity and ion permeation in L-type Ca2+ channels , 1993, Nature.

[41]  B. Chait,et al.  The structure of the potassium channel: molecular basis of K+ conduction and selectivity. , 1998, Science.

[42]  N. Klugbauer,et al.  Reconstruction of the dihydropyridine site in a non‐L‐type calcium channel: the role of the IS6 segment , 1999, FEBS letters.

[43]  S. Siegelbaum,et al.  Exposure of Residues in the Cyclic Nucleotide–Gated Channel Pore: P Region Structure and Function in Gating , 1996, Neuron.

[44]  S. Goldmann,et al.  1,4‐Dihydropyridines: Effects of Chirality and Conformation on the Calcium Antagonist and Calcium Agonist Activities , 1991 .

[45]  Peter Hess,et al.  Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists , 1984, Nature.

[46]  G. Yellen,et al.  Gated Access to the Pore of a Voltage-Dependent K+ Channel , 1997, Neuron.

[47]  Lori L. Isom,et al.  Auxiliary subunits of voltage-gated ion channels , 1994, Neuron.

[48]  W. Catterall,et al.  Molecular Determinants of High Affinity Dihydropyridine Binding in L-type Calcium Channels (*) , 1996, The Journal of Biological Chemistry.